melphalan and Back-Pain

melphalan has been researched along with Back-Pain* in 2 studies

Other Studies

2 other study(ies) available for melphalan and Back-Pain

Article	Year
Pancytopenia responding to treatment of hyperthyroidism: a clinical case and review of the literature. Clinical and laboratory haematology, 2002, Volume: 24, Issue:6 A 46-year-old-man received high dose chemotherapy and an autologous stem-cell transplant for multiple plasmacytoma. He had a prolonged period of pancytopenia post-transplantation, which was thought to be due to a suboptimal dose of transplanted stem cells in combination with the effects of interferon therapy and an altered bone marrow microenvironment. Twenty-eight months after the transplant he was found to be hyperthyroid. Anti-thyroid therapy has led to a sustained improvement in his pancytopenia. Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Back Pain; Carbimazole; Cyclophosphamide; Doxorubicin; Graves Disease; Gynecomastia; Humans; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Pancytopenia; Peripheral Blood Stem Cell Transplantation; Ribs; Spinal Neoplasms; Thoracic Vertebrae; Transplantation Conditioning; Transplantation, Autologous; Vincristine	2002
Four months with a dull pain in the back. Modern medicine of Asia, 1977, Volume: 13, Issue:3 Topics: Back Pain; Blood Protein Electrophoresis; Bone Marrow Examination; Female; Humans; Melphalan; Middle Aged; Multiple Myeloma; Prednisone	1977

Article

Year

Pancytopenia responding to treatment of hyperthyroidism: a clinical case and review of the literature.

Clinical and laboratory haematology, 2002, Volume: 24, Issue:6

A 46-year-old-man received high dose chemotherapy and an autologous stem-cell transplant for multiple plasmacytoma. He had a prolonged period of pancytopenia post-transplantation, which was thought to be due to a suboptimal dose of transplanted stem cells in combination with the effects of interferon therapy and an altered bone marrow microenvironment. Twenty-eight months after the transplant he was found to be hyperthyroid. Anti-thyroid therapy has led to a sustained improvement in his pancytopenia.

Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Back Pain; Carbimazole; Cyclophosphamide; Doxorubicin; Graves Disease; Gynecomastia; Humans; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Pancytopenia; Peripheral Blood Stem Cell Transplantation; Ribs; Spinal Neoplasms; Thoracic Vertebrae; Transplantation Conditioning; Transplantation, Autologous; Vincristine

2002

Four months with a dull pain in the back.

Modern medicine of Asia, 1977, Volume: 13, Issue:3

Topics: Back Pain; Blood Protein Electrophoresis; Bone Marrow Examination; Female; Humans; Melphalan; Middle Aged; Multiple Myeloma; Prednisone

1977